期刊文献+

基因芯片法对苏州市结核临床分离株RFP耐药性快速检测价值的研究 被引量:3

Study of the applicability of rifampicin-resistance detecting rapidly with DNA microassay chip for Mycobacterium tuberculosis isolated from clinical tuberculosis patients in Suzhou City of China Authors
在线阅读 下载PDF
导出
摘要 目的通过基因芯片法检测结核分离株RFP的耐药性,为在临床诊断中利用该法快速鉴别苏州市结核RFP耐药菌株的可靠性奠定基础。方法收集痰液标本45例,利用罗氏固体培养法(金标准)对结核分枝杆菌进行传统药敏试验;利用晶芯结核分枝杆菌耐药检测试剂盒及相关仪器通过核酸提取、PCR扩增、芯片杂交和芯片扫描,对结核分枝杆菌RFP耐药相关基因rpoB的rpoB-RRDR 511,513,516,526,531和533位点进行检测,将基因芯片检测获得的RFP药敏判读结果与金标准法获得的结果进行比较分析;将17例经基因芯片检测过的菌株用PCR法扩增包含rpoB-RRDR的基因片段,经纯化后进行DNA直接测序,将基因芯片对rpoB-RRDR 526,531位点的检测结果与DNA测序获得的结果进行比较分析。结果与金标准法相比,基因芯片法对菌株RFP药敏检测的准确率为93.3%(42/45);与DNA测序法相比,基因芯片法对rpoB-RRDR 526,531位点突变型检测的准确率为82.4%(14/17)。结论 rpoB-RRDR 526,531位点突变是导致苏州市结核病RFP耐药的主要因素,通过基因芯片法对rpoB基因相关位点的检测可为临床对RFP耐药结核鉴定提供一种快速、准确和批量性的检测手段,具有极大的应用价值。 Objective To evaluate the detection applicability of DNA microassay chip for rifampicin (RFP) -resistant Mycobacte- rium tuberculosis ( MTB ) from clinical tuberculosis (TB) patients in Snzhou City. Methods The sputum samples were gathered from TB patients in the Affiliated Hospital of Infectious Diseases of Soochow University. The conventional Lwenstein-Jensen culture medium was a- dopted to test drug sensitivity. Based on examining the RFP-resistance associated gene mutant point rpoB-RRDR 511,513,516,526,531 and 533, DNA microassay chip was adopted to detect RFP resistance. Thirdly, the rpoB-RRDR gene fragment from 17 samples tested by DNA chip was sequencing after amplification through PCR and purification. The results for RFP-sensitivity and point mutation in rpoB- RRDR fragment examined by DNA chip were respectively compared with traditional drug susceptibility test and DNA sequencing. Results Compared with the traditional drug susceptibility testing and DNA sequencing, the rate of accuracy for DNA chip evaluating RFP resist- ance and identifying point mutation in rpoB-RRDR fragment was respectively 93.3% (42/45) and 82.4% ( 14/17 ). Conclusion In Suzhou city, rpoB-RRDR 526,531 mutation mainly contributes to RFP-resistance for Mycobacterium tuberculosis and can be rapidly detec- ted by using DNA microassay chip.
出处 《临床肺科杂志》 2013年第12期2169-2172,共4页 Journal of Clinical Pulmonary Medicine
基金 苏州市科技支撑计划(No SS201241) 苏州市应用基础研究计划(No SKWQ1031 No SWKQ0824)
关键词 基因芯片 结核病 利福平 耐药 DNA测序 DNA microassay chip Tuberculosis rifampicin Drug resistance DNA sequencing
作者简介 通讯作者:肖玉梅,E-mail:liaohual963@126.com
  • 相关文献

参考文献9

  • 1虞忻,沈兴华,唐佩军,吴妹英,王霞芳.苏州市结核病耐多药情况分析[J].临床肺科杂志,2012,17(2):269-271. 被引量:10
  • 2Ramaswamy S, Musser J M. Molecular genetic basis of antimicrobi-al agent resistance in Mycobaeterium tuberculosis: 1998 update [J]. Tuber Lung Dis, 1998, 79(1) :3 -29.
  • 3Scarpellini P, Braglia S, Carrera P, et al. Detection of rifampin re- sistance in Mycobacterium tuberculosis by double gradient-denatu- ring gradient gel electrophoresis [ J ]. Antimicrob Agents Chemoth- er, 1999, 43(10) : 2550 -2254.
  • 4Herrera L, Jim6nez S, Valverde A, et al. Molecular analysis of rif- ampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996 -2001 ). Description of new mutations in the rpoB gene and review of the literature [ J]. Int J Antimicrob Agents, 2003, 21 (5) : 403 - 408.
  • 5Van Der Zanden AG, Te Koppele-Vije EM, Vijaya Bhanu Net al. Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis[J]. J Clin Microbiol, 2003, 41 (3) : 1101 - 1118.
  • 6Harding CV, Boom WH. Regulation of antigen presentation by My- cobacterium tuberculosis: a role for Toll-like receptors[ J]. Nat Rev Microbiol, 2010, 8(4): 296-307.
  • 7Kleinnijenhuis J, Oosting M, Joosten LA, et al. Innate immune recognition of Mycobacterium tuberculosis[ J]. Clin Dev Immunol, 2011, 2011:405310.
  • 8Nightingale SD, Byrd LT, Southern PM, et al. Incidence of Myco- bacterium avium-intracellulare complex bacteremia in human immu- nodeficiency virus-positive patients [ J]. J Infect Dis, 1992, 165 (6) : 1082 - 1085.
  • 9Heep M, Brandstatter B, Rieger U, et al. Frequency of rpoB muta- tions inside and outside the cluster I region in rifampin-resistant clinical Mycobaeterium tuberculosis isolates[ J]. J Clin Microbiol, 2001, 39(1) : 107 -110.

二级参考文献6

  • 1Turmbiarte Guillen N, Reyes MH, Fernandez Canton S, et al. Mortal- ity due to selected causes of infectious and chronic non-trmasmissible diseases,from 1991 to 2004 [J]. ReV Meal Inst Mex Seguro Soc, 2006,44(suppl) :Sill - 119.
  • 2Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions : 2002 - 2030 [ J]. Ann Trop Med Para- sitol,2006,100 (5 - 6) :481 - 499.
  • 3Farchi S, MantoVani J, Borgia P, et al. Tuberculosis incidence, hos- pitalisation prevalence and mortality in Lazio, Italy, 1997 -2003 [J]. Int J Tuberc Lung Dis,2008,12(2) :193 -198.
  • 4Dye C, Scheele S, Dolin P, et al. Global burden of tuberculosis : es- timated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project [ J ]. JAMA, 1999,282 (7) :677 -686.
  • 5Yang Y, Li X, Zhou F, et al. Prevalence of drug - resistant tubercu- losis in China's Mainland: systematic review and meta-analysis [ J ]. PLoS One,2011,6(6) :e20343.
  • 6He GX, Zhao YL, Jiang GL, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China[ J]. BMC Infect Dis,2008,8 : 166.

共引文献9

同被引文献48

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部